190 related articles for article (PubMed ID: 35739044)
1. AWAREness of Diagnosis and Treatment of Chronic Kidney Disease in Adults With Type 2 Diabetes (AWARE-CKD in T2D).
Chu L; Bhogal SK; Lin P; Steele A; Fuller M; Ciaccia A; Abitbol A
Can J Diabetes; 2022 Jul; 46(5):464-472. PubMed ID: 35739044
[TBL] [Abstract][Full Text] [Related]
2. Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidney disease in patients with type 2 diabetes.
Rossing P; Groehl F; Mernagh P; Folkerts K; Garreta-Rufas A; Harris J; Meredith K; Carter M; Åkerborg Ö; Wanner C; Hobbs FDR
J Med Econ; 2023; 26(1):935-943. PubMed ID: 37439218
[TBL] [Abstract][Full Text] [Related]
3. Management of chronic kidney disease in type 2 diabetes: screening, diagnosis and treatment goals, and recommendations.
Shubrook JH; Neumiller JJ; Wright E
Postgrad Med; 2022 May; 134(4):376-387. PubMed ID: 34817311
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classification.
Wang T; Xi Y; Lubwama R; Hannanchi H; Iglay K; Koro C
Diabetes Metab Syndr; 2019; 13(1):612-615. PubMed ID: 30641775
[TBL] [Abstract][Full Text] [Related]
5. Geographical variation in kidney function testing and associations with health care costs among patients with chronic kidney disease and type 2 diabetes.
Betts KA; Song J; Elliott J; Warnock N; Farej R; Wu A; Singh R
Am J Manag Care; 2022 Aug; 28(6 Suppl):S112-S119. PubMed ID: 35997775
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and Renal Outcomes in Patients with Type-2 Diabetes and Chronic Kidney Disease Identified in a United States Administrative Claims Database: A Population Cohort Study.
Folkerts K; Kelly AMB; Petruski-Ivleva N; Fried L; Blankenburg M; Gay A; Velentgas P; Kovesdy CP
Nephron; 2021; 145(4):342-352. PubMed ID: 33789294
[TBL] [Abstract][Full Text] [Related]
7. Making an impact on kidney disease in people with type 2 diabetes: the importance of screening for albuminuria.
McGill JB; Haller H; Roy-Chaudhury P; Cherrington A; Wada T; Wanner C; Ji L; Rossing P
BMJ Open Diabetes Res Care; 2022 Jul; 10(4):. PubMed ID: 35790319
[TBL] [Abstract][Full Text] [Related]
8. Glycemic Control and Cardiovascular Risk Factor Management in Adults With Type 2 Diabetes With and Without Chronic Kidney Disease Before Sodium-Glucose Cotransporter Protein 2 Inhibitors: Insights From the Diabetes Mellitus Status in Canada Survey.
Nouraei H; Leiter LA; Tan MK; Langer A; Teoh H; Cheng AYY; Wald R; Connelly KA; Goodman SG; Yan AT
Can J Diabetes; 2021 Dec; 45(8):743-749. PubMed ID: 33839025
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Chronic Kidney Disease in Type 2 Diabetes: The Canadian REgistry of Chronic Kidney Disease in Diabetes Outcomes (CREDO) Study.
Chu L; Fuller M; Jervis K; Ciaccia A; Abitbol A
Clin Ther; 2021 Sep; 43(9):1558-1573. PubMed ID: 34426012
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
[TBL] [Abstract][Full Text] [Related]
11. Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.
Pollock C; Sanchez JJG; Carrero JJ; Kumar S; Pecoits-Filho R; Lam CSP; Chen H; Kanda E; Lainscak M; Wheeler DC
Diabet Med; 2024 Feb; 41(2):e15200. PubMed ID: 37578188
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia.
Fiseha T; Tamir Z
BMC Nephrol; 2020 Apr; 21(1):129. PubMed ID: 32293323
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of chronic kidney disease in the Netherlands and its cardiovascular and renal complications.
Vervloet MG; de Jong HJ; Pander J; Overbeek JA
BMC Nephrol; 2023 Nov; 24(1):337. PubMed ID: 37957561
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
Ji E; Kim YS
Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
[TBL] [Abstract][Full Text] [Related]
15. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
[TBL] [Abstract][Full Text] [Related]
16. Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations.
Stempniewicz N; Vassalotti JA; Cuddeback JK; Ciemins E; Storfer-Isser A; Sang Y; Matsushita K; Ballew SH; Chang AR; Levey AS; Bailey RA; Fishman J; Coresh J
Diabetes Care; 2021 Sep; 44(9):2000-2009. PubMed ID: 34233925
[TBL] [Abstract][Full Text] [Related]
17. Characterising the burden of chronic kidney disease among people with type 2 diabetes in England: a cohort study using the Clinical Practice Research Datalink.
Cook S; Schmedt N; Broughton J; Kalra PA; Tomlinson LA; Quint JK
BMJ Open; 2023 Mar; 13(3):e065927. PubMed ID: 36882249
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of outpatients referred for a first consultation with a nephrologist: impact of different guidelines.
Schulz C; Messikh Z; Reboul P; Cariou S; Ahmadpoor P; Pambrun E; Prelipcean C; Garo F; Prouvot J; Delanaye P; Moranne O
J Nephrol; 2022 Jun; 35(5):1375-1385. PubMed ID: 35028894
[TBL] [Abstract][Full Text] [Related]
19. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
Otieno FCF; Ogola EN; Kimando MW; Mutai K
BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
[TBL] [Abstract][Full Text] [Related]
20. Quality of Chronic Kidney Disease Management in Canadian Primary Care.
Bello AK; Ronksley PE; Tangri N; Kurzawa J; Osman MA; Singer A; Grill AK; Nitsch D; Queenan JA; Wick J; Lindeman C; Soos B; Tuot DS; Shojai S; Brimble KS; Mangin D; Drummond N
JAMA Netw Open; 2019 Sep; 2(9):e1910704. PubMed ID: 31483474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
